Studies on the mechanism of the erythrocyte enzyme abnormalities induced by chemotherapy.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Scandinavian Journal of Haematology

• Publication date

  2009-04-24

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1111/J.1600-0609.1981.TB01419.XPMID 6452678
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Erythrocyte abnormalities induced by chemotherapy and radiotherapy: induction of preleukaemic states?

  2009cited by this paper
• Red Blood Cell Enzyme Abnormalities in Patients Treated with Chemotherapy

  1979cited by this paper
• Human erythrocyte pyruvate kinase. Total purification and evidence for its antigenic identity with L-type enzyme.

  1977cited by this paper
• [Preleukemic states].

  1977cited by this paper
• Acute nonlymphocytic leukemia. A delayed complication of Hodgkin's disease therapy: Analysis of 109 cases

  1977cited by this paper
• Acute myelogenous leukemia subsequent to therapy for a different neoplasm: Clinical features and response to therapy

  1977cited by this paper
• Causal mechanisms of multiple acquired red cell enzyme defects in a patient with acquired dyserythropoiesis.

  1976cited by this paper
• Mechanisms of the acquired erythrocyte enzyme deficiencies in blood diseases.

  1976cited by this paper
• Acquired Erythroenzymopathies in Blood Disorders: Study of 200 Cases

  1975cited by this paper
• Etude de quelques proprits de la phosphofructokinase rythrocytaire de l'homme normal

  1974cited by this paper
• "Acquired" red cell enzyme defects in hematological diseases.

  1974cited by this paper
• Starch gel electrophoresis of phosphofructokinase in red cells.

  1974cited by this paper
• Dyserythropoiesis, refractory anemia, and "preleukemia:" metabolic features of the erythrocytes.

  1973cited by this paper
• [Properties of erythrocyte phosphofructokinase in normal humans].

  1973cited by this paper
• Influence of allosteric ligands on the activity and aggregation of rabbit muscle phosphofructokinase.

  1973cited by this paper
• Erythrocyte phosphofructokinase and glucose-6-phosphate dehydrogenase in leukemia.

  1973cited by this paper
• Multimolecular forms of pyruvate kinase from rat and other mammalian tissues. I. Electrophoretic studies.

  1972cited by this paper
• Erythrocyte phosphofructokinase alterations in polycythemia vera.

  1972cited by this paper
• Physical and kinetic properties of human phosphofructokinase from skeletal muscle and erythrocytes.

  1969cited by this paper
• Biochemical variants of glucose-6-phosphate dehydrogenase giving rise to congenital nonspherocytic hemolytic disease.

  1968cited by this paper
• Frequency and serological character of changes of group ABH-antigens in blood diseases and malignant tumours.

  1967cited by this paper

• Immunological studies of PK and PFK deficiencies induced by chemotherapy.

  2009cites this paper
• Erythrocyte enzymes in polycythemia vera: a comparison to erythrocyte enzyme activities of patients with iron deficiency anemia.

  1986cites this paper
• Red cell pyruvate kinase in acute leukemia.

  1984cites this paper
• Chemotherapeutic agents and the erythron.

  1983cites this paper